Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · see citing works

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O ₂ -Regulated Prolyl Hydroxylation

Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · see citing works

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O ₂ Sensing

Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · see citing works

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617 · see citing works

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344 · see citing works

Untitled work

(1989) · PubMed · Cited by 3,343 · see citing works

Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects

Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · see citing works

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · see citing works

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · see citing works

Untitled work

(1999) · PubMed · Cited by 2,204 · see citing works

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158 · see citing works

Regulation of hypoxia-inducible factor 1α is mediated by an O ₂ -dependent degradation domain via the ubiquitin-proteasome pathway

Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · see citing works

Purification and Characterization of Hypoxia-inducible Factor 1

Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,069 · see citing works

The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022 · see citing works

Cell and environment interactions in tumor microregions: the multicell spheroid model.

Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803 · see citing works

Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions

Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674 · see citing works

Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation

Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,629 · see citing works

HIF‐1α is required for solid tumor formation and embryonic vascularization

Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579 · see citing works

Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,258 · see citing works

Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit

Huang, E. L., Arany, Z. P., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190 · see citing works

Erythropoietin: structure, control of production, and function

JELKMANN, W. E. B. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.2.449 · Cited by 1,167 · see citing works

Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1

Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17771 · Cited by 1,106 · see citing works

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · see citing works

Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.

Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990 · see citing works

Erythropoietin

Krantz, S. B. (1991) · Blood · doi:10.1182/blood.v77.3.419.419 · Cited by 881 · see citing works

Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.

Wang, G. L., & Semenza, G. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80571-7 · Cited by 863 · see citing works

Untitled work

(2002) · PubMed · Cited by 840 · see citing works

HUMAN CARBONIC ANHYDRASES AND CARBONIC ANHYDRASE DEFICIENCIES

Sly, W. S., & Hu, P. Y. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002111 · Cited by 833 · see citing works

Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis

Lu, H., Forbes, R. A., & Verma, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 832 · see citing works

Stabilization of wild-type p53 by hypoxia-inducible factor 1α

An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. Μ. (1998) · Nature · doi:10.1038/32925 · Cited by 820 · see citing works

Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis

Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743 · see citing works

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 674 · see citing works

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Brown, J. M. (1999) · PubMed · Cited by 636 · see citing works

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Graeber, T. G., Peterson, J., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 613 · see citing works

Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

Shweiki, D., Neeman, M., Itin, A., & Keshet, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.768 · Cited by 599 · see citing works

Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells

Ikeda, E., Achen, M. G., Breier, G., & Risau, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19761 · Cited by 593 · see citing works

Hypoxia and drug resistance

Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563 · see citing works

Treatment Resistance of Solid Tumors

Vaupel, P. W., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 557 · see citing works

Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

Teicher, B. A., Lazo, J. S., & Sartorelli, A. C. (1981) · PubMed · Cited by 555 · see citing works

Development and characterization of novel erythropoiesis stimulating protein (NESP)

Egrie, J. C., & Browne, J. K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1746 · Cited by 514 · see citing works

Induction of Vascular Endothelial Growth Factor by Hypoxia Is Modulated by a Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Ha-ras-Transformed Cells Through a Hypoxia Inducible Factor-1 Transcriptional Element

Mazure, N. M., Chen, E. Y., Laderoute, K. R., & Giaccia, A. J. (1997) · Blood · doi:10.1182/blood.v90.9.3322 · Cited by 498 · see citing works

Suppression of tumor growth through disruption of hypoxia-inducible transcription

Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 497 · see citing works

Untitled work

(2002) · PubMed · Cited by 457 · see citing works

Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast

Leek, R., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 450 · see citing works

Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.

Minchenko, О. H., Bauer, T., Salceda, S., & Caro, J. (1994) · PubMed · Cited by 429 · see citing works

Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis.Preprint

Lin, C. S., Lim, S. K., D’Agati, V. D., & Costantini, F. D. (1996) · Genes & Development · doi:10.1101/gad.10.2.154 · Cited by 419 · see citing works

Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression

Gardner, L. B., Li, Q., Park, M. S., Flanagan, W. M., Semenza, G. L., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010189200 · Cited by 390 · see citing works

SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

Brown, J. M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.220 · Cited by 367 · see citing works

Structure, function, and activation of the erythropoietin receptor

Youssoufian, H., Longmore, G. D., Neumann, D., Yoshimura, A., & Lodish, H. F. (1993) · Blood · doi:10.1182/blood.v81.9.2223.2223 · Cited by 353 · see citing works

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD

Claesson, L., Welsh, M., Ito, N., Anand‐Apte, B., Söker, S., Zetter, B. R., O’Reilly, M. S., & Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5579 · Cited by 345 · see citing works

The hematopoietin receptor superfamily

Cosman, D. J. (1993) · Cytokine · doi:10.1016/1043-4666(93)90047-9 · Cited by 298 · see citing works

Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group

von Pawel, J., von Roemeling, R., Gatzemeier, U., Boyer, M. J., Elisson, L. O., CLARK, P. I., Talbot, D., Rey, A. A., Butler, T. W., Hirsh, V., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1351 · Cited by 285 · see citing works

Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation

Dachs, G. U., & Tozer, G. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00159-3 · Cited by 272 · see citing works

Estrogen-dependent Production of Erythropoietin in Uterus and Its Implication in Uterine Angiogenesis

Yasuda, Y., Masuda, S., Chikuma, M., Inoue, K., Nagao, M., & Sasaki, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25381 · Cited by 263 · see citing works

Erythropoietin and erythropoietin receptor expression in human cancer.

Ács, G., Acs, P. I., Beckwith, S. M., et al. (2001) · PubMed · Cited by 240 · see citing works

Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.

Teicher, B. A., Holden, S. A., Al-Achi, A., & Herman, T. S. (1990) · PubMed · Cited by 225 · see citing works

A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress

Walker, L. J., Craig, R., Harris, A. L., et al. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.23.4884 · Cited by 224 · see citing works

The P-glycoprotein multidrug transporter

Fardel, O., Lecureur, V., & Guillouzo, A. (1996) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00081-x · Cited by 223 · see citing works

Erythropoietin stimulates proliferation of human renal carcinoma cells

Westenfelder, C. S., & Baranowski, R. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00211.x · Cited by 222 · see citing works

Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia

Schmaltz, C., Hardenbergh, P. H., Wells, A. G., & Fisher, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2845 · Cited by 217 · see citing works

DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.

Wozniak, A. J., & Ross, W. E. (1983) · PubMed · Cited by 216 · see citing works

Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein

Levy, A. P., Levy, N. S., & Goldberg, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25492 · Cited by 212 · see citing works

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

Pidgeon, G. P., Barr, M. P., Harmey, J. H., Foley, D. A., & Bouchier‐Hayes, D. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1876 · Cited by 208 · see citing works

The macrophage – a novel system to deliver gene therapy to pathological hypoxia

Griffiths, L. G., Binley, K. E., Iqball, S., Kan, O., Maxwell, P. H., Ratcliffe, P. J., Lewis, C. E., Harris, A. L., Kingsman, S. M., & Naylor, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301058 · Cited by 206 · see citing works

Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules

Netti, P. A., Hamberg, L. M., Babich, J. W., Kierstead, D., Graham, W. A., Hunter, G. J. S., Wolf, G. L., Fischman, A. J., Boucher, Y., & Jain, R. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3137 · Cited by 203 · see citing works

Biology of erythropoietin.

Lacombe, C., & Mayeux, P. (1998) · PubMed · Cited by 203 · see citing works

Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.

Claasen, H. H. V. R., Kluin, P. M., & Fleuren, G. J. (1992) · PubMed · Cited by 201 · see citing works

Functional Requirement of the Hypoxia-responsive Element in the Activation of the Inducible Nitric Oxide Synthase Promoter by the Iron Chelator Desferrioxamine

Melillo, G., Taylor, L. S., Brooks, A., Musso, T., Cox, G. W., & Varesio, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12236 · Cited by 201 · see citing works

Phase I Trial of Concurrent Tirapazamine, Cisplatin, and Radiotherapy in Patients With Advanced Head and Neck Cancer

Rischin, D., Peters, L., Hicks, R. J., Hughes, P. G., Fisher, R., Hart, R., Sexton, M., D’Costa, I., & von Roemeling, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.535 · Cited by 199 · see citing works

Immunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain

Juul, S. E., Yachnis, A. T., Rojiani, A. M., et al. (1999) · Pediatric and Developmental Pathology · doi:10.1007/s100249900103 · Cited by 199 · see citing works

Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events

Goldberg, M., Gaut, C., & Bunn, H. F. (1991) · Blood · doi:10.1182/blood.v77.2.271.271 · Cited by 199 · see citing works

Targeting gene therapy to cancer: a review.

Dachs, G. U., Dougherty, G. J., Stratford, I. J., et al. (1997) · PubMed · Cited by 187 · see citing works

Tumor Oxygenation: A New Predictive Parameter in Locally Advanced Cancer of the Uterine Cervix

Höckel, M., Vorndran, B., Schlenger, K., Baußmann, E., & Knapstein, P. G. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1262 · Cited by 184 · see citing works

Response of tumour cells to hypoxia: role of p53 and NFkB.

Royds, J. A., Dower, S., Qwarnström, E. E., & Lewis, C. E. (1998) · Molecular Pathology · doi:10.1136/mp.51.2.55 · Cited by 182 · see citing works

Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.

Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R. G., Boersma, T., & Sonneveld, P. (1995) · PubMed · Cited by 174 · see citing works

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

Skovsgaard, T. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90306-9 · Cited by 169 · see citing works

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

Mittelman, M., Neumann, D., Peled, A., Kanter, P., & Haran‐Ghera, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081275298 · Cited by 157 · see citing works

Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: Implications for anti‐angiogenic therapy

Harmey, J. H., & Bouchier‐Hayes, D. M. (2002) · BioEssays · doi:10.1002/bies.10043 · Cited by 154 · see citing works

Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy

Sun, X., Kanwar, J. R., Leung, E. Y., Lehnert, K., Wang, D., & Krissansen, G. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301388 · Cited by 146 · see citing works

Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.

Kim, C., Tsai, M. H., Osmanian, C., Graeber, T. G., Lee, J. E., Giffard, R. G., DiPaolo, J. A., Peehl, D. M., & Giaccia, A. J. (1997) · PubMed · Cited by 143 · see citing works

Tumour vasculature as a target for anticancer therapy

Eatock, M. M., Schätzlein, A. G., & Kaye, S. B. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0158 · Cited by 139 · see citing works

Regulation of glucose transport and GLUT1 glucose transporter expression by O2 in muscle cells in culture

Bashan, N., Burdett, E., Hundal, H. S., & Klip, A. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.3.c682 · Cited by 121 · see citing works

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

Morin, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204102 · Cited by 120 · see citing works

Tirapazamine: a hypoxia-activated topoisomerase II poison.

Peters, K. B., & Brown, J. (2002) · PubMed · Cited by 117 · see citing works

Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats.

Kelleher, D. K., Mattheinsen, U., Thews, O., & Vaupel, P. W. (1996) · PubMed · Cited by 114 · see citing works

Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia‐induced lethal damage

Åmellem, Ø., & Pettersen, E. O. (1991) · Cell Proliferation · doi:10.1111/j.1365-2184.1991.tb01144.x · Cited by 113 · see citing works

Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.

Thews, O., Kelleher, D. K., & Vaupel, P. W. (2001) · PubMed · Cited by 108 · see citing works

p21Cip1 and p27Kip1Regulate Cell Cycle Reentry after Hypoxic Stress but Are Not Necessary for Hypoxia-Induced Arrest

Green, S., Freiberg, R. A., & Giaccia, A. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1196-1206.2001 · Cited by 107 · see citing works

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

Silver, D. F., & Piver, M. S. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5368 · Cited by 96 · see citing works

Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.

Wang, J., BIEDERMANN, K. A., & Brown, J. (1992) · PubMed · Cited by 92 · see citing works

Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors

Negus, R. P. M., Turner, L., Burke, F., & Balkwill, F. R. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.758 · Cited by 92 · see citing works

Repopulation of γ-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors

Stephens, T. C., Currie, G. A., & Peacock, J. H. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.252 · Cited by 91 · see citing works

Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance.

Rice, G. C., Ling, V. W. T., & Schimke, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9261 · Cited by 90 · see citing works

Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation.

Tannock, I. F. (1982) · PubMed · Cited by 88 · see citing works

Distribution and Activity of Antineoplastic Drugs in a Tumor Model

Durand, R. E. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.146 · Cited by 87 · see citing works

Origin and Fate of Erythropoietin in Human Milk

Juul, S. E., Zhao, Y., Dame, J. B., et al. (2000) · Pediatric Research · doi:10.1203/00006450-200011000-00018 · Cited by 83 · see citing works

Hypoxia‐mediated regulation of gene expression in mammalian cells

Shih, S., & Claffey, K. P. (1998) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1998.00088.x · Cited by 78 · see citing works

Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.

Teicher, B. A., Holden, S. A., & Jacobs, J. L. (1987) · PubMed · Cited by 75 · see citing works

Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells.

Murphy, B. J., Laderoute, K. R., Chin, R. J., et al. (1994) · PubMed · Cited by 62 · see citing works

The role of the p53 protein in the apoptotic response

Lane, D. P., Lü, X., Hupp, T. R., et al. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0106 · Cited by 62 · see citing works

Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro

Siim, B. G., zijl, P. V., & Brown, J. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.187 · Cited by 60 · see citing works

Inhibition of the genotoxicity of bleomycin by superoxide dismutase

Cunningham, M. L., Ringrose, P. S., & Lokesh, B. R. (1984) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(84)90122-8 · Cited by 59 · see citing works

Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents.

Wozniak, A. J., Glisson, B. S., Hande, K. R., & Ross, W. E. (1984) · PubMed · Cited by 50 · see citing works

Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi

Vaupel, P. W., Schaefer, C. A., & Okunieff, P. G. (1994) · NMR in Biomedicine · doi:10.1002/nbm.1940070305 · Cited by 50 · see citing works

Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.

Ebert, M. P., Pomorski, T. G., Hoffmann, J., et al. (2000) · PubMed · Cited by 45 · see citing works

Inhibition of DNA replication by tirapazamine.

Peters, K. B., Wang, H., Brown, J. M., & Iliakis, G. E. (2001) · PubMed · Cited by 39 · see citing works

Hypoxia upregulates Bcl‐2 expression and suppresses interferon‐γ induced antiangiogenic activity in human tumor derived endothelial cells

Wang, J. H., Wu, Q. D., Bouchier-Hayes, D., & Redmond, H. P. (2002) · Cancer · doi:10.1002/cncr.10520 · Cited by 33 · see citing works

Partitioning of Ifosfamide and Its Metabolites between Red Blood Cells and Plasma

Momerency, G., Cauwenberghe, K. A. V., Highley, M., et al. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950156a · Cited by 27 · see citing works

Clinical benefit from erythropoietin

Dicato, M. A., Duhem, C., Berchem, G., & Ries, F. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00004 · Cited by 23 · see citing works

Hypoxia and disease: Opportunities for novel diagnostic and therapeutic pro-drug strategies.

Airley, R. E., Monaghan, J., & Stratford, I. J. (2000) · Research Explorer (The University of Manchester) · Cited by 18 · see citing works

Clinical efforts to modulate angiogenesis in the adult: gene therapy versus conventional approaches

Liau, G., Su, E. J., & Dixon, K. D. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01809-8 · Cited by 16 · see citing works

Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy.

Singer, S., Neuringer, L. J., Thilly, W. G., et al. (1993) · PubMed · Cited by 12 · see citing works

Erythropoetin treatment can increase 2,3-diphosphoglycerate levels in red blood cells

Birgegård, G., & Sandhagen, B. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101316911369 · Cited by 11 · see citing works

Neoplastic disease and immunosuppression

Bennett, P. N., & Brown, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-10244-8.10030-8 · Cited by 4 · see citing works

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612 · see citing works

Hypoxia, DNA repair and genetic instability

Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140 · see citing works

3D cell culture systems modeling tumor growth determinants in cancer target discovery

Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478 · see citing works

A Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies

Elliott, N. T., & Yuan, F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22257 · Cited by 449 · see citing works

Macrophage Responses to Hypoxia

Lewis, C., & Murdoch, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62038-x · Cited by 413 · see citing works

Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment

Däster, S., Amatruda, N., Calabrese, D., Ivanek, R., Turrini, E., Droeser, R. A., Zajac, P., Fimognari, C., Spagnoli, G. C., Iezzi, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.13857 · Cited by 281 · see citing works

Modulating tumor hypoxia by nanomedicine for effective cancer therapy

Jahanban‐Esfahlan, R., de la Guardia, M., Ahmadi, D., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25859 · Cited by 201 · see citing works

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

Chawla, S. P., Cranmer, L. D., Van Tine, B. A., Reed, D. R., Okuno, S. H., Butrynski, J. E., Adkins, D. R., Hendifar, A. E., Kroll, S., & Ganjoo, K. N. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3660 · Cited by 155 · see citing works

Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer

Li, F., Mei, H., Gao, Y., Xie, X., Nie, H., Li, T., Zhang, H., & Jia, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.030 · Cited by 152 · see citing works

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

Lequeux, A., Noman, M. Z., Xiao, M., Van Moer, K., Hasmim, M., Benoit, A., Bosseler, M., Viry, E., Arakelian, T., Berchem, G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01846-x · Cited by 129 · see citing works

Hypoxia signaling in cancer: Implications for therapeutic interventions

Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119 · see citing works

Progress toward Overcoming Hypoxia-Induced Resistance to Solid Tumor Therapy

Reginato, M., & Karakashev, S. (2015) · Cancer Management and Research · doi:10.2147/cmar.s58285 · Cited by 95 · see citing works

Prevention of Anastomotic Leakage after Total Gastrectomy with Perioperative Supplemental Oxygen Administration: A Prospective Randomized, Double-blind, Controlled, Single-center Trial

Schietroma, M., Cecilia, E. M., Carlei, F., Sista, F., De Santis, G., Piccione, F., & Amicucci, G. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2714-7 · Cited by 92 · see citing works

Metal peroxides for cancer treatment

He, J., Fu, L.-H., Qi, C., Lin, J., & Huang, P. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.026 · Cited by 93 · see citing works

Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study

Daponte, A., Ioannou, M., Mylonis, I., Simos, G., Minas, M., Messinis, I. E., & Koukoulis, G. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-335 · Cited by 82 · see citing works

Normobaric hyperoxia inhibits the progression of lung cancer by inducing apoptosis

Kim, S. W., Kim, I. K., Ha, J. H., Yeo, C. D., Kang, H. H., Kim, J. W., & Lee, S. H. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218774737 · Cited by 25 · see citing works

lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia

Li, L., Wang, M., Mei, Z., Cao, W., Yang, Y., Wang, Y., & An, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.113 · Cited by 128 · see citing works

Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α

Kline, D. D., Peng, Y., Manalo, D. J., Semenza, G. L., & Prabhakar, N. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022634199 · Cited by 263 · see citing works

The role of hypoxia‐inducible factor‐2 alpha in angiogenesis

Befani, C. D., & Liakos, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26805 · Cited by 118 · see citing works

Hypoxia Primes Human ISCs for Interleukin-Dependent Rescue of Stem Cell Activity

Rivera, K. R., Bliton, R. J., Burclaff, J., Czerwinski, M. J., Liu, J., Trueblood, J. M., Hinesley, C. M., Breau, K. A., Deal, H. E., Joshi, S., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.012 · Cited by 8 · see citing works

Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination

Kiraga, Ł., Cheda, Ł., Taciak, B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206706 · Cited by 23 · see citing works